UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 255

Sortiert nach

Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA trials

The lancet oncology, 2015-07, Vol.16 (7), p.775-786

2015

Volltextzugriff (PDF)

Role of HPV Genotype, Multiple Infections, and Viral Load on the Risk of High-Grade Cervical Neoplasia

Cancer epidemiology, biomarkers & prevention, 2019-11, Vol.28 (11), p.1816-1824

2019

Volltextzugriff (PDF)

A 2-Year Prospective Study of Human Papillomavirus Persistence among Women with a Cytological Diagnosis of Atypical Squamous Cells of Undetermined Significance or Low-Grade Squamous Intraepithelial Lesion

The Journal of infectious diseases, 2007-06, Vol.195 (11), p.1582-1589

2007

Volltextzugriff (PDF)

Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

The lancet oncology, 2012, Vol.13 (1), p.100-110

2012

Volltextzugriff (PDF)

Clinical follow-up practices after cervical cancer screening by co-testing: A population-based study of adherence to U.S. guideline recommendations

Preventive medicine, 2021-12, Vol.153, p.106770-106770, Article 106770

2021

Volltextzugriff (PDF)

Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical disease

Cancer epidemiology, biomarkers & prevention, 2014-10, Vol.23 (10), p.1997-2008

2014

Volltextzugriff (PDF)

Impact of screening on cervical cancer incidence: A population‐based case–control study in the United States

International journal of cancer, 2020-08, Vol.147 (3), p.887-896

2020

Volltextzugriff (PDF)

Performance of an affordable urine self-sampling method for human papillomavirus detection in Mexican women

PloS one, 2021-07, Vol.16 (7), p.e0254946-e0254946

2021

Volltextzugriff (PDF)

Human Papillomavirus Genotype Specificity of Hybrid Capture 2

Journal of Clinical Microbiology, 2008-08, Vol.46 (8), p.2595-2604

2008

Volltextzugriff (PDF)

Efficacy of the AS04-Adjuvanted HPV16/18 Vaccine: Pooled Analysis of the Costa Rica Vaccine and PATRICIA Randomized Controlled Trials

JNCI : Journal of the National Cancer Institute, 2020-08, Vol.112 (8), p.818-828

2020

Volltextzugriff (PDF)

Human Papillomavirus Genotype Distributions: Implications for Vaccination and Cancer Screening in the United States

JNCI : Journal of the National Cancer Institute, 2009-04, Vol.101 (7), p.475-487

2009

Volltextzugriff (PDF)

A Controlled Trial of a Human Papillomavirus Type 16 Vaccine

The New England journal of medicine, 2002-11, Vol.347 (21), p.1645-1651

2002

Volltextzugriff (PDF)

Human Papillomavirus Type 16 Integration in Cervical Carcinoma In Situ and in Invasive Cervical Cancer

Journal of Clinical Microbiology, 2006-05, Vol.44 (5), p.1755-1762

2006

Volltextzugriff (PDF)

Advances in primary and secondary interventions for cervical cancer: human papillomavirus prophylactic vaccines and testing

Nature clinical practice. Oncology, 2007-04, Vol.4 (4), p.224-235

Wheeler, Cosette M

2007

Volltextzugriff (PDF)

Human Papillomavirus Genotypes and the Cumulative 2-Year Risk of Cervical Precancer

The Journal of infectious diseases, 2006-11, Vol.194 (9), p.1291-1299

2006

Volltextzugriff (PDF)

HPV16 Down-Regulates the Insulin-Like Growth Factor Binding Protein 2 to Promote Epithelial Invasion in Organotypic Cultures

PLoS pathogens, 2015-06, Vol.11 (6), p.e1004988-e1004988

2015

Volltextzugriff (PDF)

Comparison of Linear Array and Line Blot Assay for Detection of Human Papillomavirus and Diagnosis of Cervical Precancer and Cancer in the Atypical Squamous Cell of Undetermined Significance and Low-Grade Squamous Intraepithelial Lesion Triage Study

Journal of Clinical Microbiology, 2008-01, Vol.46 (1), p.109-117

2008

Volltextzugriff (PDF)

The Clinical Meaning of a Cervical Intraepithelial Neoplasia Grade 1 Biopsy

Obstetrics and gynecology (New York. 1953), 2011-12, Vol.118 (6), p.1222-1229

2011

Volltextzugriff (PDF)

Detection of HPV DNA in paraffin-embedded cervical samples: a comparison of four genotyping methods

BMC infectious diseases, 2015-11, Vol.15 (1), p.544, Article 544

2015

Volltextzugriff (PDF)

New Technologies in Cervical Cancer Screening

Vaccine, 2008-08, Vol.26, p.K42-K52

2008

Volltextzugriff (PDF)

Gaps in the screening process for women diagnosed with cervical cancer in four diverse US health care settings

Cancer medicine (Malden, MA), 2023-02, Vol.12 (3), p.3705-3717

2023

Volltextzugriff (PDF)

Human papillomavirus seroprevalence and seroconversion following baseline detection of nine human papillomavirus types in young women

Tumour virus research, 2022-06, Vol.13, p.200236-200236, Article 200236

2022

Volltextzugriff (PDF)

Evidence for Frequent Regression of Cervical Intraepithelial Neoplasia-Grade 2

Obstetrics and gynecology (New York. 1953), 2009, Vol.113 (1), p.18-25

2009

Volltextzugriff (PDF)

1 – 25 von 255

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(251)
Mit Volltextzugriff
(242)

Publikationsform

Artikel
(254)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(197)
Life Sciences & Biomedicine
(194)
Humans
(190)
Female
(182)
Adult
(115)
Human Papillomavirus
(99)
Cervical Cancer
(94)
Uterine Cervical Neoplasms - Virology
(93)
Biological And Medical Sciences
(88)
Medical Sciences
(81)
Oncology
(74)
Papillomavirus Infections - Virology
(72)
Adolescent
(70)
Papillomaviridae - Genetics
(62)
Infectious Diseases
(56)
Papillomaviridae - Isolation & Purification
(54)
Tumors
(54)
Middle Aged
(52)
Cervical Intraepithelial Neoplasia - Virology
(49)
Papillomavirus Infections - Prevention & Control
(48)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA trials

Role of HPV Genotype, Multiple Infections, and Viral Load on the Risk of High-Grade Cervical Neoplasia

A 2-Year Prospective Study of Human Papillomavirus Persistence among Women with a Cytological Diagnosis of Atypical Squamous Cells of Undetermined Significance or Low-Grade Squamous Intraepithelial Lesion

Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

Clinical follow-up practices after cervical cancer screening by co-testing: A population-based study of adherence to U.S. guideline recommendations

Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical disease

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

Impact of screening on cervical cancer incidence: A population‐based case–control study in the United States

Performance of an affordable urine self-sampling method for human papillomavirus detection in Mexican women

Human Papillomavirus Genotype Specificity of Hybrid Capture 2

Efficacy of the AS04-Adjuvanted HPV16/18 Vaccine: Pooled Analysis of the Costa Rica Vaccine and PATRICIA Randomized Controlled Trials

Human Papillomavirus Genotype Distributions: Implications for Vaccination and Cancer Screening in the United States

Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials

A Controlled Trial of a Human Papillomavirus Type 16 Vaccine

Human Papillomavirus Type 16 Integration in Cervical Carcinoma In Situ and in Invasive Cervical Cancer

Advances in primary and secondary interventions for cervical cancer: human papillomavirus prophylactic vaccines and testing

Human Papillomavirus Genotypes and the Cumulative 2-Year Risk of Cervical Precancer

HPV16 Down-Regulates the Insulin-Like Growth Factor Binding Protein 2 to Promote Epithelial Invasion in Organotypic Cultures

Comparison of Linear Array and Line Blot Assay for Detection of Human Papillomavirus and Diagnosis of Cervical Precancer and Cancer in the Atypical Squamous Cell of Undetermined Significance and Low-Grade Squamous Intraepithelial Lesion Triage Study

The Clinical Meaning of a Cervical Intraepithelial Neoplasia Grade 1 Biopsy

Detection of HPV DNA in paraffin-embedded cervical samples: a comparison of four genotyping methods

New Technologies in Cervical Cancer Screening

Gaps in the screening process for women diagnosed with cervical cancer in four diverse US health care settings

Human papillomavirus seroprevalence and seroconversion following baseline detection of nine human papillomavirus types in young women

Evidence for Frequent Regression of Cervical Intraepithelial Neoplasia-Grade 2

Suchergebnisse filtern